相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent developments in esophageal adenocarcinoma
Jesper Lagergren et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
Florine Kastelein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Systematic Reviews and Meta-analyses in Clinical Gastroenterology and Hepatology
Fasiha Kanwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E2 in Patients With Barrett's Esophagus
Gary W. Falk et al.
GASTROENTEROLOGY (2012)
Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
Linda M. Liao et al.
GASTROENTEROLOGY (2012)
The Role of Bile Acids in the Neoplastic Progression of Barrett's Esophagus - A Short Representative Overview
S. Juergens et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2012)
Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study
Kee Wook Jung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study
M. Sikkema et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Stuart J. Spechler et al.
GASTROENTEROLOGY (2011)
Risk Factors for Progression of Low-Grade Dysplasia in Patients With Barrett's Esophagus
Sachin Wani et al.
GASTROENTEROLOGY (2011)
GRADE guidelines: 7. Rating the quality of evidence-inconsistency
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Marjolein Sikkema et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
GASTROENTEROLOGY (2010)
Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo
Jolanta A. Obszynska et al.
GUT (2010)
Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing
Ernst J. Kuipers
GUT (2010)
Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic Lesions
Farhad Islami et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Long-term Safety Concerns with Proton Pump Inhibitors
Tauseef Ali et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications
Ramalinga R. Kedika et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus
Piers A. C. Gatenby et al.
DISEASES OF THE ESOPHAGUS (2009)
Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett's Esophagus
Chin Hur et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Chemoprevention and Barrett's Esophagus: Decisions, Decisions
Gary W. Falk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus
L. C. Hillman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus
Pieter J. F. de Jonge et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence
BT Cooper et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer
JA Jankowski et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
RC Fitzgerald
GUT (2005)
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenes
SI Abdalla et al.
CLINICAL CANCER RESEARCH (2004)
Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor
CR Haigh et al.
GASTROENTEROLOGY (2003)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Barrett's oesophagus, dysplasia and pharmacologic acid suppression
RC Fitzgerald et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
VN Shirvani et al.
GASTROENTEROLOGY (2000)
分享论文
